SWitching to Abilify Trial (SWAT)
Clinical trial NCT00304616 · COMPLETED
Trial details
- NCT number
- NCT00304616
- Sponsor
- Korea Otsuka Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2004-10-01
- Primary completion
- 2006-06-01
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.